Evidence map›Paper›PMID 32977548›Full record

SynthesisNutrients2020

Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.

Caitlyn Vlasschaert, Chloe J Goss, Nathan G Pilkey, Sandra McKeown, Rachel M Holden

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Vitamin K and women's health: a review.Frontiers in global women's health · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. TheCurrent issues in molecular biology · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Caitlyn VlasschaertDepartment of Medicine, Queen's University, Kingston, ON K7L 3V6, Canada.
Chloe J GossDepartment of Medicine, Queen's University, Kingston, ON K7L 3V6, Canada.
Nathan G PilkeyDepartment of Medicine, Queen's University, Kingston, ON K7L 3V6, Canada.
Sandra McKeownBracken Health Sciences Library, Queen's University, Kingston, ON K7L 2V5, Canada.ORCID 0000-0002-2728-6702
Rachel M HoldenDepartment of Medicine, Queen's University, Kingston, ON K7L 3V6, Canada.
Queen's University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix gla protein (MGP) is an important vitamin K-dependent inhibitor of vascular calcification. High levels of uncarboxylated, dephosphorylated MGP have been associated with vascular calcification and are responsive to vitamin K treatment. In this systematic review, we summarize the available evidence examining whether vitamin K supplementation improves surrogate measures of cardiovascular disease including artery and valve calcification, atherosclerosis and artery stiffening. Data from controlled trials of adults were obtained by searching Ovid MEDLINE, Embase, the Cochrane Central Register of Controlled Trials and the Web of Science Core Collection. We identified nine randomized controlled trials for review, including trials of vitamin K

Indexed as

Dietary SupplementsAnimalsArteriesAtherosclerosisCalcium-Binding ProteinsCardiovascular DiseasesDatabases, FactualDisease ProgressionExtracellular Matrix ProteinsHumansMatrix Gla ProteinRandomized Controlled Trials as TopicVascular CalcificationVascular StiffnessVitamin KVitamin K 2Calcium-Binding ProteinsExtracellular Matrix ProteinsMatrix Gla ProteinVitamin KVitamin K 2arterial stiffnessatherosclerosiscardiovascular diseasematrix Gla proteinvascular calcificationvitamin K

Identifiers

PMID32977548
PMCPMC7598164
OpenAlexW3088377738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.